Human dermal fibroblasts (SpinalCyte)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman dermal fibroblasts (SpinalCyte)
Drug Alias NameCybroCell Human Dermal FibroblastsCybroCell
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsIntervertebral disc disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFibroGenesis
China Registration ClassN/A

Develop Information

Active CompaniesFibroGenesis
Inactive CompaniesN/A
Active IndicationsIntervertebral disc disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A